2.365
price down icon3.47%   -0.085
 
loading

Finanzdaten der Biocardia Inc-Aktie (BCDA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
323.08%
0.055
0.013 0.357 0.043 0.064
Operating Expenses
11.11%
2.33
2.097 2.955 3.495 3.574
Benefits Costs and Expenses
11.11%
2.33
2.097 2.955 3.495 3.574
Costs And Expenses
11.11%
2.33
2.097 2.955 3.495 3.574
Operating Income/Loss
9.17%
-2.275
-2.084 -2.598 -3.452 -3.51
Nonoperating Income/Loss
33.33%
0.008
0.012 0.024 0.028 0.009
Income/Loss From Continuing Operations Before Tax
9.17%
-2.275
-2.084 -2.598 -3.424 -3.501
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
9.41%
-2.267
-2.072 -2.574 -3.424 -3.501
Net Income/Loss
9.41%
-2.267
-2.072 -2.574 -3.424 -3.501
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,499%
25.13
0.4489 21.62 20.38 20.18
Basic Earnings Per Share
0.00%
-0.09
-0.09 -0.12 -0.17 -0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$79.95
price down icon 1.03%
$20.11
price down icon 2.71%
$347.71
price down icon 1.71%
$4.69
price down icon 6.94%
biotechnology ONC
$223.50
price down icon 2.35%
$117.61
price down icon 1.94%
Kapitalisierung:     |  Volumen (24h):